Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial

NAUnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Severe SepsisAcute Heart Failure
Interventions
DEVICE

Mespere Venus 1000 Non-Invasive CVP System

The Venus 1000 CVP System is a non-invasive central venous pressure measurement system that utilizes the proven science of NIRS. Approved by FDA, received Health Canada Medical Device Licence and CE Marked, the Venus 1000 has been proven to be clinically equivalent to measurements made via right heart catheterization.

Trial Locations (1)

Unknown

Detroit Receiving Hospital, Detroit

Sponsors
All Listed Sponsors
collaborator

Wayne State University

OTHER

lead

Mespere Lifesciences Inc.

INDUSTRY